PHUNG NGUYEN: Open Payments
NPI 1912446063 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 68 payments from 17 companies in 2025. Trend: 2023 $1,806 · 2024 $1,208 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 20 | $628 |
| Amgen Inc. | 20 | $239 |
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Novo Nordisk Inc | 4 | $63 |
| Renalytix AI, Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $43 |
| Abbott Laboratories | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Lilly USA, LLC | 1 | $33 |
| Boston Scientific Corporation | 1 | $28 |
Products named: OTEZLA, AIRSUPRA, REPATHA, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, Veozah, FARXIGA, JARDIANCE, Rybelsus.
Industry payments across AZ — which companies pay providers there.
